Benign Hepatocellular Tumors (Adenomatosis) in Nonalcoholic Steatohepatitis: A Case Report

Elizabeth M. Brunt; Michael K. Wolverson; Adrian M. Di Bisceglie

doi:10.1055/s-2005-871202

Seminars in Liver Disease, Table of Contents

Semin Liver Dis 2005; 25(2): 230-236
DOI: 10.1055/s-2005-871202

DIAGNOSTIC PROBLEMS IN HEPATOLOGY

Benign Hepatocellular Tumors (Adenomatosis) in Nonalcoholic Steatohepatitis: A Case Report

Elizabeth M. Brunt¹ ^, ² , Michael K. Wolverson³ , Adrian M. Di Bisceglie¹ ^, ⁴

¹Saint Louis University Liver Center, Saint Louis University Health Sciences Center, St. Louis, Missouri
²Departments of Pathology, Saint Louis University Health Sciences Center, St. Louis, Missouri
³Radiology, Saint Louis University Health Sciences Center, St. Louis, Missouri
⁴Internal Medicine, Saint Louis University Health Sciences Center, St. Louis, Missouri

Abstract

Full Text

References

REFERENCES

1 Ribeiro A, Burgart L J, Nagorney D M, Gores G J. Management of liver adenomatosis: results with a conservative surgical approach. Liver Transpl Surg. 1998; 4 388-398
2 Chiche L, Dao T, Salame E et al.. Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature. Ann Surg. 2000; 231 74-81
3 Boyd P R, Mark G J. Multiple hepatic adenomas and a hepatocellular carcinoma in a man on oral methyl testosterone for eleven years. Cancer. 1977; 40 1765-1770
4 Sale G E, Lerner K G. Multiple tumors after androgen therapy. Arch Pathol Lab Med. 1977; 101 600-603
5 Howell R R, Stevenson R E, Ben-Menachem Y, Phyliky R L. Hepatic adenomata with type 1 glycogen storage disease. JAMA. 1976; 236 1481-1484
6 Monaco A P, Hallgrimsson J, McDermott W V. Multiple adenoma (hamartoma) of the liver treated by subtotal (90%) resection: morphological and functional studies of regeneration. Ann Surg. 1964; 159 513-519
7 Brander W L, Vosnides G, Ogg C S, West I E. Multiple hepatocellular tumours in a patient treated with oral contraceptives. Virchows Arch A Pathol Anat Histol. 1976; 370 69-76
8 Edmondson H A, Reynolds T B, Henderson B, Benton B. Regression of liver cell adenomas associated with oral contraceptives. Ann Intern Med. 1977; 86 180-182
9 Foster J H, Donohue T A, Berman M M. Familial liver cell adenomas and diabetes mellitus. N Engl J Med. 1978; 299 239-241
10 Kalra P A, Guthrie J A, Dibble J B, Turney J H, Brownjohn A M. Hepatic adenomas induced by norethisterone in patients receiving renal dialysis. Br Med J (Clin Res Ed). 1987; 294 808
11 Liu A FK, Hiratzka L F, Hirose F M. Multiple adenomas of the liver. Cancer. 1980; 45 1001-1004
12 Sinha M R, Prasad S B. Multiple adenomas of the liver. J Indian Med Assoc. 1982; 79 16-18
13 Chen K TK, Bocian J J. Multiple hepatic adenomas (letter). Arch Pathol Lab Med. 1983; 107 274-275
14 Le Bail B, Jouhanole H, Deugnier Y et al.. Liver adenomatosis with granulomas in two patients on long-term oral contraceptives. Am J Surg Pathol. 1992; 16 982-987
15 Propst A, Propst T, Waldenberger P, Vogel W, Judmaier G. A case of hepatocellular adenomatosis with a follow-up of 11 years. Am J Gastroenterol. 1995; 90 1345-1346
16 Gokhale R, Whitington P F. Hepatic adenomatosis in an adolescent. J Pediatr Gastroenterol Nutr. 1996; 23 482-486
17 Arsenault T M, Johnson C D, Gorman B, Burgart L J. Hepatic adenomatosis. Mayo Clin Proc. 1996; 71 478-480
18 Ye M Q, Suwinata A, Hain M B, Parsons R, Schwartz M. A 42 year old woman with liver masses and long-term use of oral contraceptives. Semin Liver Dis. 1999; 19 339-344
19 Suarez A A, Brunt E M, Di Bisceglie A M. A 35 year old woman with progesterone implant contraception and multiple liver masses. Semin Liver Dis. 2001; 21 453-459
20 Flejou J F, Barge J, Menu Y et al.. Liver adenomatosis. An entity distinct from liver adenoma?. Gastroenterology. 1985; 89 1132-1138
21 Leese T, Farges O, Bismuth H. Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit. Ann Surg. 1988; 208 558-564
22 Yoshidome H, McMasters K M, Edwards M J. Management issues regarding hepatic adenomatosis. Am Surg. 1999; 65 1070-1076
23 Grazioli L, Federle M P, Ichikawa T, Balzano E, Nalesnik M, Madariaga J. Liver adenomatosis: clinical, histopathologic, and imaging findings in 15 patients. Radiology. 2000; 216 395-402
24 Bluteau O, Jeannot E, Bioulac-Sage P et al.. Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat Genet. 2002; 32 312-315
25 Bacq Y, Jacquemin E, Balabaud C et al.. Familial liver adenomatosis associated with hepatocyte nuclear factor 1α inactivation. Gastroenterology. 2003; 125 1470-1474
26 Cotrim H P, Parana R, Braga E, Lyra L. Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history?. Am J Gastroenterol. 2000; 95 3018-3019
27 Ludwig J, McGill D B, Lindor K D. Nonalcoholic steatohepatitis. J Gastroenterol Hepatol. 1997; 12 398-403
28 Orikasa H, Ohyama R, Tsukada N, Eyden B P, Yamazaki K. Lipid-rich clear-cell carcinoma arising in nonalcoholic steatohepatitis in a patient with diabetes mellitus. J Submicrosc Cytol Pathol. 2001; 33 195-200
29 Powell E E, Cooksley W G, Hanson R, Searle J, Halliday J W, Powell L W. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology. 1990; 11 74-80
30 Shimada M, Hashimoto E, Taniai M et al.. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol. 2002; 37 154-160
31 Zen Y, Katayanagi K, Tsuneyama K, Harada K, Araki I, Nakanuma Y. Hepatocellular carcinoma arising in non-alcoholic steatohepatitis. Pathol Int. 2001; 51 127-131
32 Brunt E M. Benign tumors of the liver. Clin Liver Dis. 2001; 5 1-15
33 Calle E E, Rodriguez C, Walker-Thurmond K, Thun M J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003; 348 1625-1638
34 Balkau B, Kahn H S, Courbon D, Eschwege E, Ducimetiere P. Hyperinsulinemia predicts fatal liver cancer but is inversely associated with fatal cancer at some other sites. Diabetes Care. 2001; 24 843-849
35 Nair S, Mason A, Eason J, Loss G, Perillo R P. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?. Hepatology. 2002; 36 150-155
36 Lagiou P, Kuper H, Stuver S O, Tzonou A, Trichopoulos D, Adami H O. Role of diabetes mellitus in the etiology of hepatocellular carcinoma. J Natl Cancer Inst. 2000; 92 1096-1099
37 El-Serag H B, Tran T, Everhart J E. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology. 2004; 126 460-468
38 Marchesini G, Bugianesi E, Forlani G et al.. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003; 37 917-923
39 Bugianesi E, Leone N, Vanni E et al.. Expanding the natural history of non-alcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 2002; 123 134-140
40 Ratziu V, Bonyhay L, Di Martino V et al.. Survival, liver failure and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology. 2002; 35 1485-1493
41 Marrero J A, Fontana R J, Su G L, Conjeevaram H S, Emick D M, Lok A S. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology. 2002; 36 1349-1354
42 Clark J M, Brancati F L, Diehl A M. Nonalcoholic fatty liver disease. Gastroenterology. 2002; 122 1649-1657
43 Ruhl C E, Everhart J E. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology. 2003; 124 71-79

Elizabeth M BruntM.D.

Professor of Pathology, 4th Floor, FDT, SLUH

3635 Vista Avenue, St. Louis, MO 63110

Email: bruntem@slu.edu